Anne R Meyer1, Amy C Engevik2, Toni Madorsky3, Erika Belmont3, Matthew T Stier4, Allison E Norlander5, Mark A Pilkinton6, Wyatt J McDonnell4, Jared A Weis7, Bogun Jang8, Simon A Mallal9, R Stokes Peebles10, James R Goldenring11. 1. Department of Cell and Developmental Biology, Nashville, Tennessee; Epithelial Biology Center, Nashville, Tennessee. 2. Epithelial Biology Center, Nashville, Tennessee; Section of Surgical Sciences, Nashville, Tennessee. 3. Epithelial Biology Center, Nashville, Tennessee. 4. Department of Pathology, Microbiology, and Immunology, Nashville, Tennessee. 5. Division of Allergy, Pulmonary and Critical Care Medicine, Nashville, Tennessee. 6. Division of Infectious Disease, Nashville, Tennessee; Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee. 7. Department of Biomedical Engineering, Wake Forest School of Medicine, Winston-Salem, North Carolina. 8. Department of Pathology, Jeju National University School of Medicine, Jeju, Korea. 9. Department of Pathology, Microbiology, and Immunology, Nashville, Tennessee; Division of Infectious Disease, Nashville, Tennessee; Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee. 10. Department of Pathology, Microbiology, and Immunology, Nashville, Tennessee; Division of Allergy, Pulmonary and Critical Care Medicine, Nashville, Tennessee; Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee; Nashville VA Medical Center, Nashville, Tennessee. 11. Department of Cell and Developmental Biology, Nashville, Tennessee; Epithelial Biology Center, Nashville, Tennessee; Section of Surgical Sciences, Nashville, Tennessee; Nashville VA Medical Center, Nashville, Tennessee. Electronic address: jim.goldenring@vumc.org.
Abstract
BACKGROUND & AIMS: Severe injury to the lining of the stomach leads to changes in the epithelium (reprogramming) that protect and promote repair of the tissue, including development of spasmolytic polypeptide-expressing metaplasia (SPEM) and tuft and foveolar cell hyperplasia. Acute gastric damage elicits a type-2 inflammatory response that includes production of type-2 cytokines and infiltration by eosinophils and alternatively activated macrophages. Stomachs of mice that lack interleukin 33 (IL33) or interleukin 13 (IL13) did not undergo epithelial reprogramming after drug-induced injury. We investigated the role of group 2 innate lymphoid cells (ILC2s) in gastric epithelial repair. METHODS: Acute gastric injury was induced in C57BL/6J mice (wild-type and RAG1 knockout) by administration of L635. We isolated ILC2s by flow cytometry from stomachs of mice that were and were not given L635 and performed single-cell RNA sequencing. ILC2s were depleted from wild-type and RAG1-knockout mice by administration of anti-CD90.2. We assessed gastric cell lineages, markers of metaplasia, inflammation, and proliferation. Gastric tissue microarrays from patients with gastric adenocarcinoma were analyzed by immunostaining. RESULTS: There was a significant increase in the number of GATA3-positive ILC2s in stomach tissues from wild-type mice after L635-induced damage, but not in stomach tissues from IL33-knockout mice. We characterized a marker signature of gastric mucosal ILC2s and identified a transcription profile of metaplasia-associated ILC2s, which included changes in expression of Il5, Il13, Csf2, Pd1, and Ramp3; these changes were validated by quantitative polymerase chain reaction and immunocytochemistry. Depletion of ILC2s from mice blocked development of metaplasia after L635-induced injury in wild-type and RAG1-knockout mice and prevented foveolar and tuft cell hyperplasia and infiltration or activation of macrophages after injury. Numbers of ILC2s were increased in stomach tissues from patients with SPEM compared with patients with normal corpus mucosa. CONCLUSIONS: In analyses of stomach tissues from mice with gastric tissue damage and patients with SPEM, we found evidence of type 2 inflammation and increased numbers of ILC2s. Our results suggest that ILC2s coordinate the metaplastic response to severe gastric injury.
BACKGROUND & AIMS: Severe injury to the lining of the stomach leads to changes in the epithelium (reprogramming) that protect and promote repair of the tissue, including development of spasmolytic polypeptide-expressing metaplasia (SPEM) and tuft and foveolar cell hyperplasia. Acute gastric damage elicits a type-2 inflammatory response that includes production of type-2 cytokines and infiltration by eosinophils and alternatively activated macrophages. Stomachs of mice that lack interleukin 33 (IL33) or interleukin 13 (IL13) did not undergo epithelial reprogramming after drug-induced injury. We investigated the role of group 2 innate lymphoid cells (ILC2s) in gastric epithelial repair. METHODS: Acute gastric injury was induced in C57BL/6J mice (wild-type and RAG1 knockout) by administration of L635. We isolated ILC2s by flow cytometry from stomachs of mice that were and were not given L635 and performed single-cell RNA sequencing. ILC2s were depleted from wild-type and RAG1-knockout mice by administration of anti-CD90.2. We assessed gastric cell lineages, markers of metaplasia, inflammation, and proliferation. Gastric tissue microarrays from patients with gastric adenocarcinoma were analyzed by immunostaining. RESULTS: There was a significant increase in the number of GATA3-positive ILC2s in stomach tissues from wild-type mice after L635-induced damage, but not in stomach tissues from IL33-knockout mice. We characterized a marker signature of gastric mucosal ILC2s and identified a transcription profile of metaplasia-associated ILC2s, which included changes in expression of Il5, Il13, Csf2, Pd1, and Ramp3; these changes were validated by quantitative polymerase chain reaction and immunocytochemistry. Depletion of ILC2s from mice blocked development of metaplasia after L635-induced injury in wild-type and RAG1-knockout mice and prevented foveolar and tuft cell hyperplasia and infiltration or activation of macrophages after injury. Numbers of ILC2s were increased in stomach tissues from patients with SPEM compared with patients with normal corpus mucosa. CONCLUSIONS: In analyses of stomach tissues from mice with gastric tissue damage and patients with SPEM, we found evidence of type 2 inflammation and increased numbers of ILC2s. Our results suggest that ILC2s coordinate the metaplastic response to severe gastric injury.
Authors: Brian S Kim; Kelvin Wang; Mark C Siracusa; Steven A Saenz; Jonathan R Brestoff; Laurel A Monticelli; Mario Noti; Elia D Tait Wojno; Thomas C Fung; Masato Kubo; David Artis Journal: J Immunol Date: 2014-08-25 Impact factor: 5.422
Authors: Victoria G Weis; Christine P Petersen; Jared A Weis; Anne R Meyer; Eunyoung Choi; Jason C Mills; James R Goldenring Journal: Am J Physiol Gastrointest Liver Physiol Date: 2016-11-23 Impact factor: 4.052
Authors: Charles M Leys; Sachiyo Nomura; Erin Rudzinski; Michio Kaminishi; Elizabeth Montgomery; Mary Kay Washington; James R Goldenring Journal: Hum Pathol Date: 2006-07-07 Impact factor: 3.466
Authors: Daniel R Neill; See Heng Wong; Agustin Bellosi; Robin J Flynn; Maria Daly; Theresa K A Langford; Christine Bucks; Colleen M Kane; Padraic G Fallon; Richard Pannell; Helen E Jolin; Andrew N J McKenzie Journal: Nature Date: 2010-03-03 Impact factor: 49.962
Authors: Michael R Howitt; Sydney Lavoie; Monia Michaud; Arthur M Blum; Sara V Tran; Joel V Weinstock; Carey Ann Gallini; Kevin Redding; Robert F Margolskee; Lisa C Osborne; David Artis; Wendy S Garrett Journal: Science Date: 2016-02-04 Impact factor: 47.728
Authors: Pengfei Sui; Darin L Wiesner; Jinhao Xu; Yan Zhang; Jinwoo Lee; Steven Van Dyken; Amber Lashua; Chuyue Yu; Bruce S Klein; Richard M Locksley; Gail Deutsch; Xin Sun Journal: Science Date: 2018-03-29 Impact factor: 63.714
Authors: Samuel Taylor; Yuefeng Huang; Grace Mallett; Chaido Stathopoulou; Tania C Felizardo; Ming-An Sun; Evelyn L Martin; Nathaniel Zhu; Emma L Woodward; Martina S Elias; Jonathan Scott; Nick J Reynolds; William E Paul; Daniel H Fowler; Shoba Amarnath Journal: J Exp Med Date: 2017-05-10 Impact factor: 14.307
Authors: Jonathan T Busada; Kylie N Peterson; Stuti Khadka; Xiaojiang Xu; Robert H Oakley; Donald N Cook; John A Cidlowski Journal: Gastroenterology Date: 2021-05-07 Impact factor: 33.883
Authors: Carlo De Salvo; Luca Pastorelli; Christine P Petersen; Ludovica F Buttò; Kristine-Ann Buela; Sara Omenetti; Silviu A Locovei; Shuvra Ray; Hannah R Friedman; Jacob Duijser; Wei Xin; Abdullah Osme; Fabio Cominelli; Ganapati H Mahabeleshwar; Jason C Mills; James R Goldenring; Theresa T Pizarro Journal: Gastroenterology Date: 2020-10-01 Impact factor: 22.682